39931-88-9

Basic information

• Product Name: 3,3-(ethylenedioxy)-5β,10β-epoxyestra-9(11)-ene-17-one
• Synonyms: 3,3-(ethylenedioxy)-5β,10β-epoxyestra-9(11)-ene-17-one
• CAS NO: 39931-88-9
• Molecular Weight: 330.424
• Mol File: 39931-88-9.mol
• Article Data: 26

Chemical Properties

• CAS DataBase Reference: 3,3-(ethylenedioxy)-5β,10β-epoxyestra-9(11)-ene-17-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3-(ethylenedioxy)-5β,10β-epoxyestra-9(11)-ene-17-one(39931-88-9)
• EPA Substance Registry System: 3,3-(ethylenedioxy)-5β,10β-epoxyestra-9(11)-ene-17-one(39931-88-9)

Safety Data

• Hazardous Substances Data: 39931-88-9(Hazardous Substances Data)

Upstream product

• 5571-36-8 ethylene deltenone 
• 7722-84-1 dihydrogen peroxide 

Downstream Products

• 151424-85-0 3,3-ethylenedioxy-5α-hydroxy-11β-{4'-[1',1'-(ethylenedioxy)-ethyl]phenyl}-estr-9-ene-17-one 
• 91934-77-9 (5R,8S,11R,13S,14S)-11-(4-(dimethylamino)phenyl)-5-hydroxy-13-methyl-1,4,5,6,7,8,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17(2H)-one 
• 646037-58-3 3-ethylenedioxy-5β-hydroxy-11α-{4'-[1',1'-(ethylenedioxy)-ethyl]phenyl}-estra-9-ene-17-one 
• 478157-88-9 11β-(4-(2-(diethylamino)ethoxy)-phenyl)-estra-4,9-diene-3,17-dione 
• 122833-23-2 3,3-ethylenedioxy-5α-hydroxy-11β-[4-(thiomethoxy)phenyl]-estr-9-en-17-one 
• 93678-28-5 3,3-ethylenedioxy-5α-hydroxy-11β-[4-(methoxy)phenyl]-estr-9-en-17-one 
• 646037-63-0 3-ethylenedioxy-5α-hydroxy-11β-(4'-acetyl-phenyl)-estr-9-ene-17-one 
• 940932-52-5 11β-(3,4-difluorophenyl)-3,3-[1,2-ethanediylbis(oxy)]-5α-hydroxyestr-9-en-17-one 
• 947394-74-3 3,3-ethylenedioxy-5α,17β-dihydroxy-11β-[4-(thiomethoxy)phenyl]-19-nor-17α-pregn-9-ene-21-ethyne 

Relevant articles and documents

Novel phosphorus-containing 17β-side chain mifepristone analogues as progesterone receptor antagonists

A novel series of steroidal compounds were designed and synthesized with various phosphorus-containing groups on the 17β-side chain as progesterone receptor antagonists. The structure-activity relationships of these compounds are discussed. Selected compo

SOLID FORMS AND FORMULATIONS COMPRISING A GLUCOCORTICOID RECEPTOR ANTAGONIST AND USES THEREOF

The present invention relates generally to formulations and methods for treating cancer. Provided herein are formulations comprising substituted steroidal derivatives. The subject formulations are useful for the treatment of cancer.

First synthesis and characterization for the stereoisomers of Ulipristal acetate

The three stereoisomers, 11α,17α-isomer I, 11α,17β-isomer II and 11β,17β-isomer III are related substances of the selective progesterone receptor modulator Ulipristal acetate. Herein, we presented an efficient and practical synthesis approach to deliver t